We manufacture an ELISA to measure a novel inflammatory marker, gamma prime fibrinogen. This is a platform technology that can be used to assess disease severity of several different inflammatory diseases, including COVID-19 and cardiovascular diseases. We are working towards a point-of-care device so that gamma prime fibrinogen can be measured in ... Read more
As an inflammatory marker, gamma prime fibrinogen is over 6x more stable than the gold standard marker, hs-CRP, and is a predictor of death from cardiovascular diseases, including heart attack, stroke and peripheral artery disease. Not only is gamma prime fibrinogen a marker of cardiovascular disease risk, but high levels cause faster, greater bloo... Read more
